Vaginal microbiota: Composition, protective role, associated pathologies, and therapeutic perspectives;La microbiota vaginal: Composición, papel protector, patología asociada y perspectivas terapéuticas

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 26, Issue 3, 2008, Pages 160-167

  Martín, Rebeca ^a   Soberón, Nora ^a   Vázquez, Fernando ^a,b   Suárez, Juan Evaristo ^a  

^a DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^b HOSPITAL MONTE NARANCO   (Spain)

Author keywords

Lactobacillus; Microbial antagonism; Probiotics; Vaginal microbiota; Vaginal pathology

Indexed keywords

PROBIOTIC AGENT;

ATOPOBIUM; BACTEREMIA; BACTERIAL COLONIZATION; BACTERICIDAL ACTIVITY; BACTERIUM ADHERENCE; BACTEROIDES; BIFIDOBACTERIUM; CANDIDA; CLOSTRIDIUM; CORYNEBACTERIUM; ENDOCARDITIS; ESCHERICHIA COLI; EUBACTERIUM; GARDNERELLA; GRAM POSITIVE BACTERIUM; HUMAN; IMMUNE DEFICIENCY; KLEBSIELLA; LACTOBACILLUS; LACTOBACILLUS CRISPATUS; LACTOBACILLUS GASSERI; LACTOBACILLUS JENSENII; MYCOPLASMA; NONHUMAN; PEPTOCOCCUS; PEPTOSTREPTOCOCCUS; PREVOTELLA; PROPIONIBACTERIUM; PROTEUS; REVIEW; STAPHYLOCOCCUS; STREPTOCOCCUS; TAXONOMY; TRICHOMONIASIS; UREAPLASMA; URINARY TRACT INFECTION; VAGINA CANDIDIASIS; VAGINA EPITHELIUM; VAGINA FLORA; VAGINA MUCOSA; VAGINITIS;

EID: 40949085557     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1157/13116753     Document Type: Review

References (89)

1. Eschenbach DA, Davick PR, Williams BL, Klebanoff SJ, Young-Smith K, Critchlow CM, et al. Prevalence of hydrogen peroxide-producing Lactobacillus species in normal women and women with bacterial vaginosis. J Clin Microbiol. 1989;27:251-6.
2. Zoetendal EG, Vaughan EE, De Vos WM. A microbial world within us. Mol Microbiol. 2006;59:1639-50.
3. Bayó M, Berlanga M, Agut M. Vaginal microbiota in healthy pregnant women and prenatal screening of group B streptococci (GBS). Int Microbiol. 2002;5:87-90.
4. Álvarez-Olmos MI, Barousse MM, Rajan L, Van Der Pol BJ, Fortenberry D, Orr D, et al. Vaginal lactobacilli in adolescents: presence and relationship to local and systemic immunity, and to bacterial vaginosis. Sex Trans Dis. 2004;31:393-400.
5. Matsumiya Y, Kato N, Watanabe K, Kato H. Molecular epidemiological study of vertical transmission of vaginal Lactobacillus species from mothers to newborn infants in Japanese, by arbitrarily primed polymerase chain reaction. J Infect Chemother. 2002;8:43-9.
6. Burton JP, Cadieux PA, Reid G. Improved understanding of the bacterial vaginal microbiota of women before and after probiotic instillation. Appl Environ Microbiol. 2003;69:97-101.
7. Zhou X, Bent S, Schneider M, Davis C, Islam M, Forney L. Characterization of vaginal microbial communities in adult healthy women using cultivation-independent methods. Microbiology. 2004;150:2565-73.
8. Döderlein ASG. Das Scheidensekret und seine bedeutung für das puerperalfieber. Leipzig: O. Durr; 1892.
9. Redondo-López V, Cook RL, Sobel JD. Emerging role of lactobacilli in the control and maintenance of the vaginal bacterial microflora. Rev Infect Dis. 1990;12:856-72.
10. Boris S, Barbés C. Role played by lactobacilli in controlling the population of vaginal pathogens. Microbes Infect. 2000;2:543-6.
11. Lepargneur JP, Rousseau V. Rôle portecteur de la flore de Doderleïn. J Gynecol Obstet Biol Reprod. 2002;31:485-94.
12. Wylie JG, Henderson A. Identity and glycogen-fermenting ability of lactobacilli isolated from the vagina of pregnant women. J Med Microbiol. 1969;2:363-6.
13. Rogosa M, Sharpe ME. Species differentiation of human vaginal lactobacilli. J Gen Microbiol. 1960;23:197-201.
14. Boyd MA, Antonio MA, Hillier SL. Comparison of API 50 CH strips to whole-chromosomal DNA probes for identification of Lactobacillus species. J Clin Microbiol. 2005;43:5309-11.
15. Song YL, Kato N, Matsumiya Y, Liu CX, Kato H, Watanabe K. Identification of Lactobacillus species of human origin by a commercial kit, API50CHL. Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi. 1999;10:77-82.
16. Song Y, Kato N, Matsumiya Y, Liu C, Kato H, Watanabe K. Identification of and hydrogen peroxide production by fecal and vaginal lactobacilli isolated from Japanese women and newborn infants. J Clin Microbiol. 1999;37:3062-4.
17. Vallor AC, Antonio MA, Hawes SE, Hillier SL. Factors associated with acquisition of, or persistent colonization by, vaginal lactobacilli: role of hydrogen peroxide production. J Infect Dis. 2001;184:1431-6.
18. Pavolva S, Killic A, Killic S, So J, Nader-Macias M, Simões J, et al. Genetic diversity of vaginal lactobacilli from women in different countries based on 16S rRNA gene sequences. J Appl Microbiol. 2002;92:451-9.
19. Hyman R, Fukushima M, Diamond L, Kumm J, Giudice L, Davis R. Microbes on the human vaginal epithelium. Proc Natl Acad Sci USA. 2005;102:7952-7.
20. Reid G, Burton J, Devillard E. The rationale for probiotics in female urogenital healthcare. Med Gen Med. 2004;29:6-49.
21. Chan RC, Reid G, Irvin RT, Bruce AW, Costerton JW. Competitive exclusion of uropathogens from human uroepithelial cells by Lactobacillus whole cells and cell wall fragments. Infect Immun. 1985;47:84-9.
22. Reid G, Servin AL, Bruce AW, Busscher HJ. Adhesion of three Lactobacillus strains to human urinary and intestinal epithelial cells. Microbios. 1993;75:57-65.
23. Boris S, Suárez JE, Barbes C. Characterization of the aggregation promoting factor from Lactobacillus gasseri, a vaginal isolate. J Appl Microbiol. 1997;83:413-20.
24. Nagy E, Froman G, Mardh PA. Fibronectin binding of Lactobacillus species isolated from women with and without bacterial vaginosis. J Med Microbiol. 1992;37:38-42.
25. Szoke I, Pascu C, Nagy E, Ljung A, Wadstrom T. Binding of extracellular matrix proteins to the surface of anaerobic bacteria. J Med Microbiol. 1996;45:338-43.
26. Boris S, Suárez JE, Vázquez F, Barbés C. Adherence of human vaginal lactobacilli to vaginal epithelial cells and interaction with uropathogens. Infect Immun. 1998;66:1985-9.
27. Chan RC, Bruce AW, Reid G. Adherence of cervical, vaginal and distal urethral normal microbial flora to human uroepithelial cells and the inhibition of adherence of gram-negative uropathogens by competitive exclusion. J Urol. 1984;131:596-601.
28. Osset J, García E, Bartolomé RM, Andreu A. Role of Lactobacillus as protector against vaginal candidiasis. Med Clin. 2001;117:285-8.
29. Osset J, Bartolomé RM, García E. Assessment of the capacity of Lactobacillus to inhibit the growth of uropathogens and block their adhesion to vaginal epithelial cells. J Infect Dis. 2001;183:485-91.
30. Amsel R, Totten PA, Spiegel CA, Chen KC, Eschenbach D, Holmes KK. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med. 1983;74:14-22.
31. Hay AD, Fahey T. Clinical diagnosis of urinary tract infection. JAMA. 2002;288:1229; author reply 1230-1.
32. Steward-Tull BA. Evidence that vaginal lactobacilli do not ferment glycogen. Am J Obstert Gynecol. 1964;88:676-9.
33. Dellaglio F, De Roissart H, Torriani S, Curk MC, Janssens D. Caractéristiques générales des bactéries lactiques. En: de Roissart H, Luquet FM, editors. Bactéries Lactiques. Vol. I. Uriag: Lorica; 1994. p. 25-116.
34. Boskey ER, Cone RA, Whaley KJ, Moench TR. Origins of vaginal acidity: high D/L lactate ratio is consistent with bacteria being the primary source. Hum Reprod. 2001;16:1809-13.
35. Antonio MA, Rabe LK, Hillier SL. Colonization of the rectum by Lactobacillus species and decreased risk of bacterial vaginosis. J Infect Dis. 2005;192:394-8.
36. Hawes SE, Hillier SL, Benedetti J, Stevens CE, Koutsky LA, Wolner-Hanssen P, et al. Hydrogen peroxide-producing lactobacilli and acquisition of vaginal infections. J Infect Dis. 1996;174:1058-63.
37. Amant DC, Valentin-Bon IE, Jerse AE. Inhibition of Neisseria gonorrhoeae by Lactobacillus species that are commonly isolated from the female genital tract. Infect Immun. 2002;70:7169-71.
38. Klebanov S, Belding M. Virucidal activity of H2O2-generating bacteria: requirement for peroxidase and halide. J Infect Dis. 1974;129:345-8.
39. Klebanov SJ, Waltersdorph AM. Prooxidant activity of transferrin and lactoferrin. J Exp Med. 1990;172:1293-303.
40. Nes IF, Diep DB, Havarstein LS, Brurberg MB, Eijsink V, Holo H. Biosynthesis of bacteriocins in lactic acid bacteria. Antonie Van Leeuwenhoek. 1996;70:113-28.
41. Wiedemann I, Bottiger T, Bonelli RR, Schneider T, Sahl HG, Martínez B. Lipid II-based antimicrobial activity of the lantibiotic plantaricin C. Appl Environ Microbiol. 2006;72:2809-14.
42. Aroutcheva AA, Simões JA, Faro S. Antimicrobial protein produced by vaginal Lactobacillus acidophilus that inhibits Gardnerella vaginalis. Infect Dis Obstet Gynecol. 2001;9:33-9.
43. Ocaña VS, Pesce De Ruiz Holgado AA, Nader-Macías ME. Characterization of a bacteriocin-like substance produced by a vaginal Lactobacillus salivarius strain. Appl Environ Microbiol. 1999;65:5631-5.
44. Velraeds MM, Van de Belt-Gritter B, Van der Mei HC, Reid G, Busscher HJ. Interference in initial adhesion of uropathogenic bacteria and yeasts to silicone rubber by a Lactobacillus acidophilus biosurfactant. J Med Microbiol. 1998;47:1081-5.
45. Velraeds MM, Van de Belt-Gritter B, Busscher HJ, Reid G, Van der Mei HC. Inhibition of uropathogenic biofilm growth on silicone rubber in human urine by lactobacilli-a teleologic approach. World J Urol. 2000;18:422-6.
46. Vollenbroich D, Ozel M, Vater J, Kamp RM, Pauli G. Mechanism of inactivation of enveloped viruses by the biosurfactant surfactin from Bacillus subtilis. Biologicals. 1997;25:289-97.
47. Vollenbroich D, Pauli G, Ozel M, Vater J. Antimycoplasma properties and application in cell culture of surfactin, a lipopeptide antibiotic from Bacillus subtilis. Appl Environ Microbiol. 1997;63:44-9.
48. García-Rodríguez JA, Muñoz JL. Vaginosis bacteriana ¿enfermedad infecciosa o alteración ecológica? Enferm Infecc Microbiol Clin. 1991;9:265-7.
49. Sobel JD. Bacterial vaginosis. Annu Rev Med. 2000;51:349-56.
50. Thorsen P, Jensen IP, Jeune B, Ebbesen N, Arpi M, Bremmelgaard A, et al. Few microorganisms associated with bacterial vaginosis may constitute the pathologic care: a population-based microbiologic studi among 3596 pregnant women. Am J Obstet Gynecol. 1998;169:450-4.
51. a ed. Buenos Aires; Panamericana, 1997. p. 1197-214.
52. a ed. Buenos Aires: Panamericana; 1997. p. 2796-801.
53. Reid G, Bruce AW. Urogenital infections in women: can probiotics help? World J Urol. 2003;24:28-32.
54. Sobel JD. Candidal vulvovaginitis. Clin Obstet Gynecol.1993;36:153-65.
55. Soriano F, Fernández R. Infección en la embarazada. Infección en obstetricia y ginecología. En: García- Rodríguez JA, Picazo JJ, editores. Microbiología Médica, 2 Microbiología Clínica. Madrid: Mosby; 1996. p. 345-61.
56. Boskey ER, Telsh KM, Whatey KI, Moench TR, Cone RA. Acid production by vaginal flora in vitro is consistent with the rate and extent of vaginal acidification. Infect Immun. 1999;67:5170-5.
57. Hay P. Life in the littoral zone: lactobacilli losing the plot. Sex Transm Infec. 2005;81:100-2.
58. Wilson J. Managing recurrent bacterial vaginosis. Sex Transm Infect. 2004;80:8-11.
59. Schreiber CA, Meyn LA, Creinin MD, Barnhart KT, Hillier SL. Effects of long-term use of nonoxynol-9 on vaginal flora. Obstet Gynecol. 2006;107:136-43.
60. Reid G, Bruce AW, Cook RL, Llano M. Effect on urogenital flora of antibiotic therapy for urinary tract infection. Scand J Infect Dis. 1990;22:43-7.
61. Carta G, Di Stefano L, Porzio G, Caserta D, Mascaretti G. Bacterial vaginosis during chemotherapy for gynecological neoplasms. A therapeutic proposal. Minerva Ginecol. 1995;47:5-8.
62. Penney GC, Thomson M, Norman J, McKenzie H, Vale L, Smith R, et al. A randomised comparison of strategies for reducing infective complications of induced abortion. Proc Natl Acad Sci U S A. 1998;95:8739-43.
63. Sweankambo N, Gray NH, Wawer MJ, Paxton L, McNaim D, Wabwire-Mangen F, et al. HIV infection associated with abnormal vaginal flora morphology and bacterial vaginosis. Lancet. 1997;1350:546-50.
64. Wiesenfeld HC, Hillier SL, Krohn MA, Landers DV, Sweet RL. Bacterial vaginosis is a strong predictor of Neisseria gonorrhoeae and Chlamydia trachomatis infection. Clin Infect Dis. 2003;36:663-8.
65. Reid G, Bruce AW. Probiotics to prevent urinary tract infections: the rationale and evidence. World J Urol 2006;24:28-32.
66. Bruce AW, Chadwick P, Hassan A, Van Cott GF. Recurrent urethritis in women. Can Med Assoc J. 1973;108:973-6.
67. Stamey TA. The role of introital enterobacteria in recurrent urinary infections. J Urol. 1973;109:467-72.
68. Raz R, Gennesin Y, Wasser J, Stoler Z, Rosenfeld S, Rottensterich E, et al. Recurrent urinary tract infections in postmenopausal women. Clin Infect Dis. 2000;30:152-6.
69. Raz R. Hormone replacement therapy or prophylaxis in postmenopausal women with recurrent urinary tract infection. J Infect Dis. 2001;183:S74-6.
70. Cannon JP, Lee TA, Bolanos JT, Danziger LH. Pathogenic relevance of Lactobacillus: a retrospective review of over 200 cases. Eur J Clin Microbiol Infect Dis. 2005;24:31-40.
71. Gasser, F. Safety of lactic acid bacteria and their occurrence in human clinical infections. Bull Inst Pasteur. 1994;92:45-67.
72. Salminen MK, Tynkkynen S, Rautelin H, Saxelin M, Vaara M, Ruutu P, et al. Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland. Clin Infect Dis. 2002;35:1155-60.
73. Saxelin M, Chuang NH, Chassy B, Rautelin H, Makela PH, Salminen S, et al. Lactobacilli and bacteremia in southern Finland, 1989-1992. Clin Infect Dis. 1996;22:564-6.
74. Borriello SP, Hammes WP, Holzapfel W, Marteau P, Schrezenmeir J, Vaara M, et al. Safety of probiotics that contain lactobacilli or bifidobacteria. Clin Infect Dis. 2003;36:775-80.
75. Álvarez-Olmos MI, Oberhelman RA. Probiotic agents and infectious diseases: a modern perspective on a traditional therapy. Clin Infect Dis. 2001;32:1567-76.
76. Cunningham-Rundles S, Ahrne S, Bengmark S, Johann-Liang R, Marshall F, Metakis L. Probiotics and immune response. Am J Gastroenterol. 2000;95(1 Suppl):S22-5.
77. Salminen MK, Rautelin H, Tynkkynen S, Poussa T, Saxelin M, Valtonen V, Jarvinen A. Lactobacillus bacteremia, species identification, and antimicrobial susceptibility of 85 blood isolates. Clin Infect Dis. 2006;42:35-44.
78. Sanders ME. Probiotics: considerations for human health. Nutr Rev. 2003;61:91-9.
79. Metchnikoff E. The Prolongation of Life: Optimistic Studies. London: William Heinemann; 1907.
80. Tannock GW. A special fondness for lactobacilli. Appl Environ Microbiol. 2004;70:3189-94.
81. Newman D. The treatment of cistitis by intravesical injections of lactic bacillus cultures. Lancet. 1915 ii, 330.
82. Andreu A. Lactobacillus as a probiotic for preventing urogenital infections. Rev Med Microbiol. 2004;15:1-6.
83. Ozkinay E, Terek MC, Yayci M, Kaiser R, Grob P, Tuncay G. The effectiveness of live lactobacilli in combination with low dose oestriol (Gynoflor) to restore the vaginal flora after treatment of vaginal infections. BJOG. 2005;112:234-40.
84. Reid G, Charbonneau D, Erb J, Kochanowski B, Beuerman D, Poehner R, et al. Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. FEMS Immunol Med Microbiol. 2003;35:131-4.
85. Reid G, Bruce AW, Taylor M. Instillation of Lactobacillus and stimulation of indigenous organisms to prevent recurrence of urinary tract infections. Microecol Ther. 1995;23:32-45.
86. Brumfitt W, Hamilton-Miller JM, Walker S, Roberts D. Cefaclor as a prophylactic agent for recurrent urinary infections: a comparative trial with macrocrystalline nitrofurantoin. Drugs Exp Clin Res. 1992;18:239-44.
87. Reid G, Bruce AW, Fraser N, Heinemann C, Owen J, Henning B. Oral probiotics can resolve urogenital infections. Immunol Med Microbiol. 2001;30:49-52.
88. Reid G, Bruce AW, Taylor M. Influence of three-day antimicrobial therapy and lactobacillus vaginal suppositories on recurrence of urinary tract infections. Clin Ther. 1992;14:11-6.
89. Anukam K, Osazuwa E, Ahonkhai I, Ngwu M, Osemene G, Bruce AW, et al. Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial. Microbes Infect. 2006;8:1450-4.